These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 2754705)
41. Improved delivery through biological membranes XX: Nicotinamide----dihydronicotinamide based ester-linked redox carrier systems. Bodor N; Abdelim AM J Pharm Sci; 1986 Jan; 75(1):29-35. PubMed ID: 2937906 [TBL] [Abstract][Full Text] [Related]
42. Evaluation of the brain-specific delivery of radioiodinated (iodophenyl)alkyl-substituted amines coupled to a dihydropyridine carrier. Tedjamulia ML; Srivastava PC; Knapp FF J Med Chem; 1985 Nov; 28(11):1574-80. PubMed ID: 4067987 [TBL] [Abstract][Full Text] [Related]
43. Evidence for suppression of serum LH without elevation in serum estradiol or prolactin with a brain-enhanced redox delivery system for estradiol. Anderson WR; Simpkins JW; Brewster ME; Bodor N Life Sci; 1988; 42(16):1493-502. PubMed ID: 3352462 [TBL] [Abstract][Full Text] [Related]
44. Involvement of Mrp2/MRP2 in the species different excretion route of benzylpenicillin between rat and human. Choi MK; Kim H; Han YH; Song IS; Shim CK Xenobiotica; 2009 Feb; 39(2):171-81. PubMed ID: 19255943 [TBL] [Abstract][Full Text] [Related]
45. Chemical delivery systems for drugs containing an amino group: synthesis and properties of some pyridine derivatives of desipramine. Pop E; Wu WM; Shek E; Bodor N Drug Des Deliv; 1989 Dec; 5(2):93-115. PubMed ID: 2577990 [TBL] [Abstract][Full Text] [Related]
46. Improved delivery through biological membranes. XXXVII. Synthesis and stability of novel redox derivatives of naproxen and indomethacin. Phelan MJ; Bodor N Pharm Res; 1989 Aug; 6(8):667-76. PubMed ID: 2813259 [TBL] [Abstract][Full Text] [Related]
47. Metabolism and penetration through blood-brain barrier of parkinsonism-related compounds. 1,2,3,4-Tetrahydroisoquinoline and 1-methyl-1,2,3,4-tetrahydroisoquinoline. Kikuchi K; Nagatsu Y; Makino Y; Mashino T; Ohta S; Hirobe M Drug Metab Dispos; 1991; 19(1):257-62. PubMed ID: 1673411 [TBL] [Abstract][Full Text] [Related]
48. Comparative neurotoxicity of benzylpenicillin, imipenem/cilastatin and FCE 22101, a new injectible penem. Schliamser SE; Broholm KA; Liljedahl AL; Norrby SR J Antimicrob Chemother; 1988 Nov; 22(5):687-95. PubMed ID: 3209527 [TBL] [Abstract][Full Text] [Related]
49. Improved brain delivery of benzylpenicillin with a peptide-vector-mediated strategy. Rousselle C; Clair P; Temsamani J; Scherrmann JM J Drug Target; 2002 Jun; 10(4):309-15. PubMed ID: 12164379 [TBL] [Abstract][Full Text] [Related]
50. Brain-specific delivery of naproxen using different carrier systems. Mahmoud S; Mohammad A Arch Pharm (Weinheim); 2010 Nov; 343(11-12):639-47. PubMed ID: 21110306 [TBL] [Abstract][Full Text] [Related]
51. Neurotoxicity of benzylpenicillin in experimental renal failure and Enterobacter cloacae meningitis. Schliamser SE; Bolander H; Broholm KA; Gerdes U; Kourtopoulos H; Norrby SR J Antimicrob Chemother; 1989 Aug; 24(2):215-25. PubMed ID: 2793645 [TBL] [Abstract][Full Text] [Related]
52. Improved delivery through biological membranes XIX: Novel redox carriers for brain-specific chemical delivery systems. Bodor N; AbdelAlim AM J Pharm Sci; 1985 Mar; 74(3):241-5. PubMed ID: 4009430 [TBL] [Abstract][Full Text] [Related]
53. Effect of cyclodextrins on the degradation rate of benzylpenicillin. Popielec A; Fenyvesi É; Yannakopoulou K; Loftsson T Pharmazie; 2016 Feb; 71(2):68-75. PubMed ID: 27004370 [TBL] [Abstract][Full Text] [Related]
54. Improved delivery through biological membranes. XXI. Brain-targeted anti-convulsive agents. Woodard PA; Winwood D; Brewster ME; Estes KS; Bodor N Drug Des Deliv; 1990 May; 6(1):15-28. PubMed ID: 2078285 [TBL] [Abstract][Full Text] [Related]
55. A dihydropyridine conjugate which generates high and sustained levels of the corresponding pyridinium salt in the brain does not exhibit neurotoxicity in cynomolgus monkeys. Brewster ME; Estes KS; Perchalski R; Bodor N Neurosci Lett; 1988 May; 87(3):277-82. PubMed ID: 3380349 [TBL] [Abstract][Full Text] [Related]
57. Efficacy of a 3-substituted versus 17-substituted chemical delivery system for estradiol brain targeting. Brewster ME; Druzgala PJ; Anderson WR; Huang MJ; Bodor N; Pop E J Pharm Sci; 1995 Jan; 84(1):38-43. PubMed ID: 7714741 [TBL] [Abstract][Full Text] [Related]
58. A redox-based chemical delivery system that enhances estradiol distribution to the brain: disposition studies in the rat. Estes KS; Keuth V; Dietzel K; Brewster ME; Bodor NS; Derendorf H Pharm Res; 1991 Sep; 8(9):1180-5. PubMed ID: 1788164 [TBL] [Abstract][Full Text] [Related]
59. AIDS dementia: synthesis and properties of a derivative of 3'-azido-3'-deoxythymidine (AZT) that may become 'locked' in the central nervous system. Torrence PF; Kinjo J; Lesiak K; Balzarini J; De Clercq E FEBS Lett; 1988 Jul; 234(1):135-40. PubMed ID: 3164686 [TBL] [Abstract][Full Text] [Related]
60. Elimination of a quaternary pyridinium salt delivered as its dihydropyridine derivative from brain of mice. Bodor N; Roller RG; Selk SJ J Pharm Sci; 1978 May; 67(5):685-7. PubMed ID: 641811 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]